GSK May Pay As Much As $1.03 Billion For 75% Stake In India Unit
This article was originally published in PharmAsia News
Executive Summary
GlaxoSmithKline's U.K. headquarters is willing to pay as much as $1.03 billion to gain 75% of the shares of its India subsidiary GSK Pharmaceuticals, but apparently seeks no higher control.